Johnson & Johnson (NYSE: JNJ) is -0.62% lower on its value in year-to-date trading and has touched a low of $144.95 and a high of $175.97 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The JNJ stock was last observed hovering at around $155.22 in the last trading session, with the day’s gains setting it 0.55%.
Currently trading at $155.77, the stock is -2.06% and -2.01% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 6.86 million and changing 0.35% at the moment leaves the stock -2.35% off its SMA200. JNJ registered 2.04% gain for a year compared to 6-month gain of -2.80%. The firm has a 50-day simple moving average (SMA 50) of $4.48 and a 200-day simple moving average (SMA200) of $16.37.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -3.12% loss in the last 1 month and extending the period to 3 months gives it a 0.20%, and is -0.28% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 0.89% over the week and 1.18% over the month.
Johnson & Johnson (JNJ) has around 131900 employees, a market worth around $375.21B and $93.02B in sales. Current P/E ratio is 27.93 and Fwd P/E is 14.17. Profit margin for the company is 15.23%. Distance from 52-week low is 7.46% and -11.48% from its 52-week high. The company has generated returns on investments over the last 12 months (14.80%).
Johnson & Johnson quarterly earnings per share for the current quarter are estimated at $2.63 with sales reaching $21.4B over the same period.The EPS is expected to grow by 7.43% this year, but quarterly earnings will post 3.80% year-over-year. Quarterly sales are estimated to shrink -13.50% in year-over-year returns.
Johnson & Johnson (JNJ) Top Institutional Holders
4,781 institutions hold shares in Johnson & Johnson (JNJ), with institutional investors hold 71.35% of the company’s shares. The shares outstanding are 2.41B, and float is at 2.40B with Short Float at 0.62%. Institutions hold 71.28% of the Float.
The top institutional shareholder in the company is Vanguard Group Inc with over 247.48 million shares valued at $40.96 billion. The investor’s holdings represent 9.52% of the JNJ Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 199.34 million shares valued at $33.0 billion to account for 7.67% of the shares outstanding. The other top investors are State Street Corporation which holds 141.83 million shares representing 5.46% and valued at over $23.48 billion, while Geode Capital Management, LLC holds 1.91% of the shares totaling 49.7 million with a market value of $8.23 billion.
Johnson & Johnson (JNJ) Insider Activity
The most recent transaction is an insider sale by Broadhurst Vanessa,the company’sEVP, Global Corp Affairs. SEC filings show that Broadhurst Vanessa sold 8,891 shares of the company’s common stock on Mar 13 ’24 at a price of $162.16 per share for a total of $1.44 million. Following the sale, the insider now owns 15043.0 shares.
Johnson & Johnson disclosed in a document filed with the SEC on Feb 16 ’24 that JOHNSON & JOHNSON (10% Owner) sold a total of 3,725 shares of the company’s common stock. The trade occurred on Feb 16 ’24 and was made at $25.81 per share for $96142.0. Following the transaction, the insider now directly holds 4.1 million shares of the JNJ stock.
Still, SEC filings show that on Feb 09 ’24, Taubert Jennifer L (EVP, WW Chair, Pharmaceuticals) disposed off 59,397 shares at an average price of $156.27 for $9.28 million. The insider now directly holds 141,416 shares of Johnson & Johnson (JNJ).
